Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study.
Shah
Sanjiv J
SJ
Department of Medicine, University of California, San Francisco, California 94143-0124, USA. sshah@medicine.ucsf.edu
Hsu
Chi-Yuan
CY
D000111:Acetylcysteine / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D015986:Confounding Factors, Epidemiologic; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D007674:Kidney Diseases / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged
D003287:Contrast Media; D000111:Acetylcysteine